BIOCRYST PHARMACEUTICALS, INC. Increase (Decrease) in Derivative Assets
BIOCRYST PHARMACEUTICALS, INC. (BCRX) reported Increase (Decrease) in Derivative Assets of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-27.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDerivativeAssets · last filed 2023-02-27
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in derivative assets for the quarter ending 2021-12-31 was $0.00.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in derivative assets for the quarter ending 2021-09-30 was $0.00.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in derivative assets for the quarter ending 2021-06-30 was $0.00.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in derivative assets for the quarter ending 2021-03-31 was $0.00.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in derivative assets for fiscal 2022 was $0.00.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in derivative assets for fiscal 2021 was $0.00.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in derivative assets for fiscal 2020 was -$632.00K.
- BIOCRYST PHARMACEUTICALS, INC. increase (decrease) in derivative assets for fiscal 2019 was -$347.00K.
| Period end | Increase (Decrease) in Derivative Assets 3 month | Increase (Decrease) in Derivative Assets 6 month | Increase (Decrease) in Derivative Assets 6 month as first filed | Increase (Decrease) in Derivative Assets 9 month | Increase (Decrease) in Derivative Assets 12 month |
|---|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-27 | ||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $0.00 derived: sum of 2 quarters · filed 2023-02-27 | $0.00 derived: sum of 3 quarters · filed 2023-02-27 | $0.00 10-K · filed 2023-02-27 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | -$2.00K derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | -$2.00K derived: sum of 3 quarters · filed 2023-02-27 | -$42.00K derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 | -$2.00K derived: sum of 2 quarters · filed 2023-02-27 | -$42.00K derived: sum of 3 quarters · filed 2023-02-27 | -$612.00K derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$42.00K derived: sum of 2 quarters · filed 2023-02-27 | -$612.00K derived: sum of 3 quarters · filed 2023-02-27 | -$632.00K 10-K · filed 2023-02-27 | |
| 2020-09-30 | -$40.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$610.00K derived: sum of 2 quarters · filed 2021-11-04 | -$630.00K 10-Q · filed 2021-11-04 | -$445.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | -$570.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$590.00K 10-Q · filed 2021-08-09 | -$405.00K derived: sum of 3 quarters · filed 2022-02-28 | -$291.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-03-31 | -$20.00K 10-Q · filed 2021-05-07 | $165.00K derived: sum of 2 quarters · filed 2022-02-28 | $279.00K derived: sum of 3 quarters · filed 2022-02-28 | -$773.00K derived: sum of 4 quarters · filed 2022-02-28 | |
| 2019-12-31 | $185.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $299.00K derived: sum of 2 quarters · filed 2022-02-28 | -$753.00K derived: sum of 3 quarters · filed 2022-02-28 | -$347.00K 10-K · filed 2022-02-28 | |
| 2019-09-30 | $114.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$938.00K derived: sum of 2 quarters · filed 2020-11-06 | -$532.00K 10-Q · filed 2020-11-06 | -$975.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | -$646.00K 10-Q · filed 2020-08-07 | -$1.09M derived: sum of 3 quarters · filed 2021-03-01 | -$510.00K derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $406.00K 10-Q · filed 2020-05-11 | -$37.00K derived: sum of 2 quarters · filed 2021-03-01 | $542.00K derived: sum of 3 quarters · filed 2021-03-01 | $1.16M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | -$443.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $136.00K derived: sum of 2 quarters · filed 2021-03-01 | $755.00K derived: sum of 3 quarters · filed 2021-03-01 | -$1.05M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $579.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.20M derived: sum of 2 quarters · filed 2019-11-08 | -$606.00K 10-Q · filed 2019-11-08 | $286.00K derived: sum of 4 quarters · filed 2020-03-13 | |
| 2018-06-30 | $619.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$1.19M 10-Q · filed 2019-08-08 | -$293.00K derived: sum of 3 quarters · filed 2020-03-13 | -$208.00K derived: sum of 4 quarters · filed 2020-03-13 | |
| 2018-03-31 | -$1.80M 10-Q · filed 2019-05-09 | -$912.00K derived: sum of 2 quarters · filed 2020-03-13 | -$827.00K derived: sum of 3 quarters · filed 2020-03-13 | -$1.23M derived: sum of 4 quarters · filed 2020-03-13 | |
| 2017-12-31 | $892.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $977.00K derived: sum of 2 quarters · filed 2020-03-13 | $577.00K derived: sum of 3 quarters · filed 2020-03-13 | -$966.00K 10-K · filed 2020-03-13 | |
| 2017-09-30 | $85.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$315.00K derived: sum of 2 quarters · filed 2018-11-08 | -$1.86M 10-Q · filed 2018-11-08 | $6.33M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-06-30 | -$400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$1.94M 10-Q · filed 2018-08-09 | $6.24M derived: sum of 3 quarters · filed 2019-03-14 | $5.31M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-03-31 | -$1.54M 10-Q · filed 2018-05-09 | $6.64M derived: sum of 2 quarters · filed 2019-03-14 | $5.71M derived: sum of 3 quarters · filed 2019-03-14 | $2.02M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2016-12-31 | $8.18M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $7.25M derived: sum of 2 quarters · filed 2019-03-14 | $3.56M derived: sum of 3 quarters · filed 2019-03-14 | $811.00K 10-K · filed 2019-03-14 | |
| 2016-09-30 | -$931.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$4.62M derived: sum of 2 quarters · filed 2017-11-08 | -$7.37M 10-Q · filed 2017-11-08 | -$7.14M derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-06-30 | -$3.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$6.44M 10-Q · filed 2017-08-08 | -$6.21M derived: sum of 3 quarters · filed 2018-03-12 | -$6.67M derived: sum of 4 quarters · filed 2018-03-12 | |
| 2016-03-31 | -$2.75M 10-Q · filed 2017-05-08 | -$2.52M derived: sum of 2 quarters · filed 2018-03-12 | -$2.98M derived: sum of 3 quarters · filed 2018-03-12 | -$3.78M derived: sum of 4 quarters · filed 2018-03-12 | |
| 2015-12-31 | $229.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$232.00K derived: sum of 2 quarters · filed 2018-03-12 | -$1.03M derived: sum of 3 quarters · filed 2018-03-12 | -$564.00K 10-K · filed 2018-03-12 | |
| 2015-09-30 | -$461.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$1.26M derived: sum of 2 quarters · filed 2016-11-08 | -$793.00K 10-Q · filed 2016-11-08 | $3.96M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-06-30 | -$796.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$332.00K 10-Q · filed 2016-08-08 | $4.42M derived: sum of 3 quarters · filed 2017-02-27 | $8.51M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2015-03-31 | $464.00K 10-Q · filed 2016-05-09 | $5.22M derived: sum of 2 quarters · filed 2017-02-27 | $9.30M derived: sum of 3 quarters · filed 2017-02-27 | $7.48M derived: sum of 4 quarters · filed 2017-02-27 | |
| 2014-12-31 | $4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $8.84M derived: sum of 2 quarters · filed 2017-02-27 | $7.01M derived: sum of 3 quarters · filed 2017-02-27 | $5.49M 10-K · filed 2017-02-27 | |
| 2014-09-30 | $4.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $2.26M derived: sum of 2 quarters · filed 2015-11-06 | $732.00K 10-Q · filed 2015-11-06 | $2.86M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2014-06-30 | -$1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$3.35M 10-Q · filed 2015-08-07 | $3.35M 10-Q · filed 2014-08-08 | -$1.22M derived: sum of 3 quarters · filed 2016-02-26 | $5.01M derived: sum of 4 quarters · filed 2016-02-26 |
| 2014-03-31 | -$1.53M 10-Q · filed 2015-05-08 | $600.00K derived: sum of 2 quarters · filed 2016-02-26 | $6.84M derived: sum of 3 quarters · filed 2016-02-26 | $1.81M derived: sum of 4 quarters · filed 2016-02-26 | |
| 2013-12-31 | $2.13M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $8.37M derived: sum of 2 quarters · filed 2016-02-26 | $3.34M derived: sum of 3 quarters · filed 2016-02-26 | $5.29M 10-K · filed 2016-02-26 | |
| 2013-09-30 | $6.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $1.21M derived: sum of 2 quarters · filed 2014-11-07 | $3.17M 10-Q · filed 2014-11-07 | ||
| 2013-06-30 | -$5.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | -$3.07M 10-Q · filed 2014-08-08 | |||
| 2013-03-31 | $1.96M 10-Q · filed 2014-05-09 | ||||
| 2012-12-31 | -$749.00K 10-K · filed 2015-03-02 | ||||
| 2011-12-31 | -$4.00M 10-K · filed 2014-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |